Daisy-chaining two of Dell's Nvidia GB10 DGX Spark systems didn't just pump up my home AI lab—it fundamentally changed how I ...

When I entered the index business more than 30 years ago, the sequence for including an initial public offering in an index was routine and took some time. Companies went public, built liquidity, ...

FTSE Russell, Nasdaq, and S&P Dow Jones Indices have decided, through their respective consultations, what they'll do about new mega-cap companies going public. In the most immediate terms, one thing ...

S&P Global said on Thursday it was not changing the requirements for entry into its major indices, dealing a setback to Elon Musk's SpaceX by effectively ruling out a swift entry for the world's ...

The FTSE Russell and Nasdaq paved the way to include mega IPOs like SpaceX into their indexes. Elon Musk's rocket startup is getting the Very Important IPO treatment—with some caveats. Major index ...

Elon Musk's rocket startup is getting the Very Important IPO treatment—with some caveats. Major index providers, including the LSEG's FTSE Russell and the Nasdaq, have made it easier for new mega-cap ...

Welcome to Jumbo June! Later this month, SpaceX should launch a stock offering expected to raise something like $80 billion. Yesterday, Anthropic announced it’s filed for an IPO of its own. Counting ...

One of the best lessons investors received when the Dow Jones Industrial Average DJIA turned 130 years old on May 26 was a reminder of why time diversification is so important in the stock market. I’m ...

Everyone wants to know what’s in the ground, air and water. The first step to getting those answers is underway. NJ.com learned that new environmental testing of a toxic landfill in Keyport that ...

Investing seems complex when you first start, but picking the right investment funds for beginners can make it much more straightforward, and give you an easy on-ramp to building your wealth over the ...

Ryan Breslow of Bolt addressed his unorthodox move during a conference in Atlanta Taylor Hill/Getty Ryan Breslow, the CEO of fintech company Bolt, spoke at a Fortune magazine conference on May 19 ...

While Create’s autoimmune pipeline is entirely preclinical, it has dosed more than 50 patients in trials of its cancer candidates. (iStock / Getty Images Plus) As the wave of in vivo CAR-T hype crests ...